{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:25:17Z","timestamp":1783049117102,"version":"3.54.6"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00685561","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T06:40:23Z","timestamp":1101710423000},"page":"377-384","source":"Crossref","is-referenced-by-count":9,"title":["Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker"],"prefix":"10.1007","volume":"34","author":[{"given":"K. S.","family":"Sridhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Krishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S. A.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sauerteig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"McPhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Auguste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"142","volume":"12","author":"NL Bartlett","year":"1993","unstructured":"Bartlett NL, Fisher GA, Halsey J, Eshan MN, Lum BL, Sikic BI (1993) A phase I trial of doxorubicin (D) with cyclosporine (CSA) as a modulator of multidrug resistance (MDR). Proc Am Soc Clin Oncol 12: 142","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR2","first-page":"859","volume":"67","author":"JL Biedler","year":"1983","unstructured":"Biedler JL, Chang T, Meyers MB, Peterson RH, Spengler BA (1983) Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67: 859","journal-title":"Cancer Treat Rep"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/0003-4819-118-8-199304150-00010","volume":"118","author":"AS Braverman","year":"1993","unstructured":"Braverman AS (1993) Chemotherapeutic failure: resistance or insensitivity? Ann Intern Med 118: 630","journal-title":"Ann Intern Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-118-8-199304150-00011","volume":"118","author":"BA Chabner","year":"1993","unstructured":"Chabner BA (1993) Biological basis for cancer treatment. Ann Intern Med 118: 633","journal-title":"Ann Intern Med"},{"key":"CR5","first-page":"2544","volume":"53","author":"G Chen","year":"1993","unstructured":"Chen G, Ramachandran C, Krishan A (1993) Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein. Cancer Res 53: 2544","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","volume":"86","author":"C Cordon-Cardo","year":"1988","unstructured":"Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1988) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1200\/JCO.1989.7.4.415","volume":"7","author":"WS Dalton","year":"1989","unstructured":"Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7: 415","journal-title":"J Clin Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0005-2736(73)90191-0","volume":"323","author":"K Dano","year":"1973","unstructured":"Dano K (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 323: 466","journal-title":"Biochim Biophys Acta"},{"key":"CR9","first-page":"395","volume-title":"BMDP statistical software manual, vol I","year":"1990","unstructured":"Dixon WJ, Brown MB, Ergelman L, Jenrich RI (eds) (1990) BMDP statistical software manual, vol I. University of California Press, Berkeley, p 395"},{"key":"CR10","first-page":"5056","volume":"44","author":"R Ganapathi","year":"1981","unstructured":"Ganapathi R, Grabowski D, Rouse W, Riegler F (1981) Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Cancer Res 44: 5056","journal-title":"Cancer Res"},{"key":"CR11","first-page":"2200","volume":"39","author":"M Inaba","year":"1979","unstructured":"Inaba M, Kobayashi H, Sakurai Y, Johnson RK (1979) Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res 39: 2200","journal-title":"Cancer Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/scientificamerican0389-44","volume":"260","author":"N Kartner","year":"1989","unstructured":"Kartner N, Ling V (1989) Multidrug resistance in cancer. Sci Am 260: 44","journal-title":"Sci Am"},{"key":"CR13","first-page":"1257","volume":"69","author":"MG Kris","year":"1985","unstructured":"Kris MG, Gralla RJ, Clark RA, Tyson LB, Fiore JJ, Kelsen DP, Groshen S (1985) Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treat Rep 69: 1257","journal-title":"Cancer Treat Rep"},{"key":"CR14","first-page":"1046","volume":"45","author":"A Krishan","year":"1985","unstructured":"Krishan A, Sauerteig A, Wellham L (1985) Flow cytometric studies on modulation of anthracycline transport by phenothiazines. Cancer Res 45: 1046","journal-title":"Cancer Res"},{"key":"CR15","first-page":"1768","volume":"46","author":"A Krishan","year":"1986","unstructured":"Krishan A, Sauerteig A, Gordon K, Swinkin C (1986) Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells. Cancer Res 46: 1768","journal-title":"Cancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/cyto.990080311","volume":"8","author":"A Krishan","year":"1987","unstructured":"Krishan A, Sridhar KS, Davila E, Vogel C, Sternheim W (1987) Patterns of anthracycline retention modulation in human tumor cells. Cytometry 8: 306","journal-title":"Cytometry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood.V77.2.348.348","volume":"77","author":"M Lehnert","year":"1991","unstructured":"Lehnert M, Dalton WS, Roe D, Emerson S, Salmon SE (1991) Synergistic inhibition by verapamil and quinine of P-glycoprotein mediated multidrug resistance in a human myeloma cell line. Blood 77: 348","journal-title":"Blood"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.1993.11.9.1652","volume":"11","author":"AF List","year":"1993","unstructured":"List AF, Spier C, Greer J, Wolff S, Hunter J, Dorr R, Salmon S, Futscher B, Baer M, Dalton W (1993) Phase I\/II trial of cyclosporine as chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11: 1652","journal-title":"J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.1992.10.10.1635","volume":"10","author":"BL Lum","year":"1992","unstructured":"Lum BL, Kaubisch S, Yamada AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI (1992) Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 10: 1635","journal-title":"J Clin Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.1988.6.5.880","volume":"6","author":"RL Miller","year":"1988","unstructured":"Miller RL, Bukowski RM, Budd GT, et al (1988) Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I\/II trial. J Clin Oncol 6: 880","journal-title":"J Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0277-5379(89)90104-1","volume":"25","author":"IN Olver","year":"1989","unstructured":"Olver IN, Webster LK, Bishop JF, Clarke J, Hillcoat BL (1989) A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy. Eur J Cancer Clin Oncol 25: 1457","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.1987.5.4.641","volume":"5","author":"RF Ozols","year":"1987","unstructured":"Ozols RF, Cunnion RE, Klecker RW, Hamilton TC, Ostchega Y, Parillo JE, Young RC (1987) Verapamil and Adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 5: 641","journal-title":"J Clin Oncol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.me.42.020191.001425","volume":"42","author":"I Pastan","year":"1991","unstructured":"Pastan I, Gottesman MM (1991) Multidrug resistance. Annu Rev Med 42: 277","journal-title":"Annu Rev Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/path.1711670103","volume":"167","author":"M Ramael","year":"1992","unstructured":"Ramael M, Bossche J van den, Buysse C, Meerbeeck J van, Segers K, Vermeire P, Marck E van (1992) Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1. J Pathol 167: 5","journal-title":"J Pathol"},{"key":"CR25","first-page":"4392","volume":"44","author":"A Ramu","year":"1984","unstructured":"Ramu A, Glaubiger D, Fuks Z (1984) Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 44: 4392","journal-title":"Cancer Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1080\/01483918008062796","volume":"3","author":"J Robert","year":"1980","unstructured":"Robert J (1980) Extraction of anthracyclines from biological fluids for HPLC evaluation. J Liquid Chromatogr 3: 1561","journal-title":"J Liquid Chromatogr"},{"key":"CR27","first-page":"1785","volume":"38","author":"T Skovsgaard","year":"1978","unstructured":"Skovsgaard T (1978) Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38: 1785","journal-title":"Cancer Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1986.167","volume":"54","author":"LM Slater","year":"1986","unstructured":"Slater LM, Sweet P, Stupecki M, Wetzel MW, Gupta S (1986) Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer 54: 235","journal-title":"Br J Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0378-4347(87)80344-4","volume":"423","author":"CS Smith","year":"1987","unstructured":"Smith CS, Morgan SL, Greene SV (1987) Solid-phase extraction and high-performance liquid chromotagraphic method for chlorpromazine and thirteen metabolites. J Chromatogr 423: 207","journal-title":"J Chromatogr"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00000421-198712000-00008","volume":"10","author":"KS Sridhar","year":"1987","unstructured":"Sridhar KS, Varki J, Donnelly E, Davila E, Benedetto P, Hilsenbeck S, Thurer RJ, Rao RK, Beattie EJ (1987) Toxicity of FED chemotherapy in non-small cell lung cancer. Am J Clin Oncol 10: 499","journal-title":"Am J Clin Oncol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jso.2930380312","volume":"38","author":"KS Sridhar","year":"1988","unstructured":"Sridhar KS, Thurer R, Kim Y, Fountzilas G, Davila E, Donnelly E, Charyulu KKN, Saldana MJ, Thomson T, Benedetto P, Raskin N, Beattie EJ (1988) Multimodality treatment of non-small cell lung cancer: response to cisplatin, VP16, and 5-FU chemotherapy and to surgery and radiation therapy. J Surg Oncol 38: 193","journal-title":"J Surg Oncol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/1097-0142(19901115)66:10<2082::AID-CNCR2820661007>3.0.CO;2-5","volume":"66","author":"KS Sridhar","year":"1990","unstructured":"Sridhar KS, Samy TSA, Agarwal RP, Duncan RC, Benedetto P, Krishan A, Vogel CL, Feun LG, Savaraj NM, Richman SP, Zubrod CG (1990) A phase I study of 4?-O-tetrahydropyranyladriamycin. Cancer 66: 2082","journal-title":"Cancer"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/1097-0142(19921215)70:12<2969::AID-CNCR2820701239>3.0.CO;2-A","volume":"70","author":"KS Sridhar","year":"1992","unstructured":"Sridhar KS, Doria R, Raub WA, Thurer R, Saldana M (1992) New strategies are needed in diffuse malignant mesothelioma. Cancer 70: 2969","journal-title":"Cancer"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00685030","volume":"31","author":"K Sridhar","year":"1993","unstructured":"Sridhar K, Krishan A, Samy TSA, Sauerteig A, Wellham L, McPhee G, Duncan R, Anac S, Ardalan B, Benedetto P (1993) Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies. Cancer Chemother Pharmacol 31: 423","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ssu.2980090209","volume":"9","author":"KS Sridhar","year":"1993","unstructured":"Sridhar KS, Thurer RJ, Markoe AM, Chatoor HT, Fountzilas G, Raub WJ, Savaraj N, Beattie EJ (1993) Multidisciplinary approach to the treatment of locally and regionally advanced non-small cell lung cancer: University of Miami experience. Semin Surg Oncol 9: 114","journal-title":"Semin Surg Oncol"},{"key":"CR36","first-page":"7775","volume":"50","author":"AN Staroselsky","year":"1990","unstructured":"Staroselsky AN, Fan D, Obrain CA, Bucana CD, Gupta KP, Fidler IJ (1990) Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin. Cancer Res 50: 7775","journal-title":"Cancer Res"},{"key":"CR37","first-page":"2905","volume":"43","author":"T Tsuruo","year":"1983","unstructured":"Tsuruo T, Lida H, Nojine M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43: 2905","journal-title":"Cancer Res"},{"key":"CR38","volume-title":"Fundamentals of clinical pharmacokinetics","author":"JG Wagner","year":"1975","unstructured":"Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Illinois"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685561\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T11:08:26Z","timestamp":1585998506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00685561"],"URL":"https:\/\/doi.org\/10.1007\/bf00685561","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}